GT CAPITAL
GT Capital is a fully market-oriented private equity investment platform under the Junyao Group-Aijian Group. It was jointly established by Aijian Group and Tang Zurong, Liu Dongjie, and Zhang Fan from China-US large investment banks and investment veterans in September 2017. Based on the "technology + people" concept, we invest in companies driven by advanced technology and work closely with entrepreneurial teams with ambitious visions and strong execution capabilities. We are a professional ... investment organization that can provide excellent services to the investee companies. With the help of our strong shareholder resources, first-class institutional investor resources, and the strategic cooperation alliances we have built across regions and industries, Provide outstanding services in governance, strategic planning, and execution, business development, listing and mergers, and acquisitions. We have set up offices in Shanghai and Beijing, and will further set up new offices in Shenzhen and Chengdu. By then, the investment radius will cover economically active areas such as Beijing, East China, Guangshen, Chengdu and Chongqing.
GT CAPITAL
Industry:
Asset Management Financial Services FinTech
Founded:
2017-09-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro Microsoft Azure DNS ASP.NET DigiCert SSL Encryption Everywhere China Telecom
Similar Organizations
Guofang Capital
Guofang Capital is a professional market-based equity investment platform with an asset under management.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-01-07 | Senko Mirco-electronics | GT Capital investment in Series B - Senko Mirco-electronics | N/A |
2020-03-30 | Zhenge Biotech | GT Capital investment in Series A - Zhenge Biotech | 51 M USD |
2020-02-10 | Universal Medical Imaging | GT Capital investment in Series B - Universal Medical Imaging | N/A |
2020-01-01 | CF PharmTech | GT Capital investment in Series E - CF PharmTech | 630 M CNY |